EG20275A - Calcium channel blacking polypeptides from filistato hibernalis - Google Patents

Calcium channel blacking polypeptides from filistato hibernalis

Info

Publication number
EG20275A
EG20275A EG29993A EG29993A EG20275A EG 20275 A EG20275 A EG 20275A EG 29993 A EG29993 A EG 29993A EG 29993 A EG29993 A EG 29993A EG 20275 A EG20275 A EG 20275A
Authority
EG
Egypt
Prior art keywords
pct
hibernalis
calcium channel
filistato
blacking
Prior art date
Application number
EG29993A
Other languages
English (en)
Inventor
Steven D Heck
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG20275A publication Critical patent/EG20275A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EG29993A 1992-05-21 1993-05-18 Calcium channel blacking polypeptides from filistato hibernalis EG20275A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88707392A 1992-05-21 1992-05-21

Publications (1)

Publication Number Publication Date
EG20275A true EG20275A (en) 1998-05-31

Family

ID=25390404

Family Applications (1)

Application Number Title Priority Date Filing Date
EG29993A EG20275A (en) 1992-05-21 1993-05-18 Calcium channel blacking polypeptides from filistato hibernalis

Country Status (26)

Country Link
US (1) US5804554A (el)
EP (1) EP0672056B1 (el)
JP (1) JP2572715B2 (el)
KR (1) KR950701647A (el)
CN (1) CN1034123C (el)
AT (1) ATE155488T1 (el)
AU (1) AU668170B2 (el)
BR (1) BR9306388A (el)
CA (1) CA2134889C (el)
CZ (1) CZ284794A3 (el)
DE (1) DE69312320T2 (el)
DK (1) DK0672056T3 (el)
EG (1) EG20275A (el)
ES (1) ES2105261T3 (el)
FI (1) FI932284A (el)
GR (1) GR3024690T3 (el)
HU (1) HUT64570A (el)
IL (1) IL105694A (el)
MX (1) MX9302925A (el)
MY (1) MY108890A (el)
NO (1) NO944417L (el)
NZ (1) NZ252452A (el)
RU (1) RU2106358C1 (el)
TW (1) TW336938B (el)
WO (1) WO1993023428A1 (el)
ZA (1) ZA933493B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461032A (en) * 1991-03-01 1995-10-24 Fmc Corporation Insecticidally effective peptides
IL104419A0 (en) * 1992-01-24 1993-05-13 Fmc Corp Insecticidally effective peptides
US5457178A (en) * 1993-07-07 1995-10-10 Fmc Corporation Insecticidally effective spider toxin
US5756459A (en) * 1995-06-07 1998-05-26 Fmc Corporation Insecticidally effective peptides isolatable from phidippus spider venom
CO5180581A1 (es) * 1999-09-30 2002-07-30 Pfizer Prod Inc Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239059A (en) * 1991-05-10 1993-08-24 The Children's Hospital Of Philadelphia Ion-channel forming peptides

Also Published As

Publication number Publication date
DK0672056T3 (da) 1997-12-08
EP0672056B1 (en) 1997-07-16
CZ284794A3 (en) 1995-08-16
RU94046023A (ru) 1996-10-10
BR9306388A (pt) 1998-09-15
CN1034123C (zh) 1997-02-26
IL105694A0 (en) 1993-09-22
HUT64570A (en) 1994-01-28
ZA933493B (en) 1994-11-21
JP2572715B2 (ja) 1997-01-16
GR3024690T3 (en) 1997-12-31
NO944417D0 (no) 1994-11-18
NO944417L (no) 1994-11-18
TW336938B (en) 1998-07-21
HU9301476D0 (en) 1993-09-28
DE69312320T2 (de) 1997-10-30
KR950701647A (ko) 1995-04-28
MY108890A (en) 1996-11-30
ES2105261T3 (es) 1997-10-16
CA2134889C (en) 1998-03-31
CN1080931A (zh) 1994-01-19
AU668170B2 (en) 1996-04-26
MX9302925A (es) 1993-11-01
FI932284A (fi) 1993-11-22
EP0672056A1 (en) 1995-09-20
US5804554A (en) 1998-09-08
CA2134889A1 (en) 1993-11-25
NZ252452A (en) 1996-07-26
WO1993023428A1 (en) 1993-11-25
IL105694A (en) 1998-02-22
ATE155488T1 (de) 1997-08-15
DE69312320D1 (de) 1997-08-21
FI932284A0 (fi) 1993-05-19
AU4117893A (en) 1993-12-13
JPH07503735A (ja) 1995-04-20
RU2106358C1 (ru) 1998-03-10

Similar Documents

Publication Publication Date Title
GR3024637T3 (en) Calcium channel blocking polypeptide from agelenopsis aperta.
EG20275A (en) Calcium channel blacking polypeptides from filistato hibernalis
TW272196B (el)
CA2146367A1 (en) Calcium channel blocking polypeptides from heteropoda venatoria